HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endurance shuttle walking test: responsiveness to salmeterol in COPD.

Abstract
Few studies have shown that the endurance shuttle walking test (ESWT) is responsive to treatment in patients with chronic obstructive pulmonary disease (COPD). This exercise test needs to be further investigated because of its relevance for activity of daily living. The aim of the present study was to evaluate, in patients with COPD, the responsiveness of the ESWT in detecting improvement in walking performance after a single dose of salmeterol. In a randomised, double-blind, placebo-controlled crossover trial, 20 patients with COPD performed two ESWT at 80% of peak capacity 2.5 h after inhaling either a placebo or 50 microg of salmeterol. Cardiorespiratory parameters were monitored during each walking test. Inspiratory capacities and Borg ratings for dyspnoea were obtained every other minute throughout the tests. Compared with placebo, salmeterol produced a significant change in lung function and a significant improvement in walking performance (mean+/-sd difference in time: 117+/-20 s; difference in distance: 160+/-277 m). At isotime (the latest exercise time that was reached on both ESWT), a significant reduction in dyspnoea was observed after bronchodilation. Bronchodilation with salmeterol reduced dyspnoea during walking and improved walking capacity in patients with chronic obstructive pulmonary disease. These findings provide further support for the use of the endurance shuttle walking test as an evaluative tool in chronic obstructive pulmonary disease.
AuthorsC Brouillard, V Pepin, J Milot, Y Lacasse, F Maltais
JournalThe European respiratory journal (Eur Respir J) Vol. 31 Issue 3 Pg. 579-84 (Mar 2008) ISSN: 1399-3003 [Electronic] England
PMID18057052 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Bronchodilator Agents
  • Salmeterol Xinafoate
  • Albuterol
Topics
  • Aged
  • Albuterol (analogs & derivatives, pharmacology)
  • Bronchodilator Agents (pharmacology)
  • Cohort Studies
  • Cross-Over Studies
  • Double-Blind Method
  • Dyspnea (drug therapy)
  • Exercise Test
  • Exercise Tolerance (drug effects)
  • Female
  • Forced Expiratory Volume (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive (drug therapy)
  • Salmeterol Xinafoate
  • Vital Capacity (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: